JY
PEPLU

Jeff Yass’s PepperLime Health Acquisition Corporation Unit PEPLU Stock Holding History

Jeff Yass’s Portfolio PEPLU Stock Details PEPLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,656
Closed -$106K – 14709
2022
Q3 		$106K Buy
+10,656
New +$106K ﹤0.01% 11658

Other funds holding PEPLU

CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $226M AUM 6.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jeff Yass's PEPLU Position: Q4 2022 in Review

Jeff Yass sold out of PepperLime Health Acquisition Corporation Unit (PEPLU) in Q4 2022, closing a stake of 10,656 shares — an estimated $106K sold.

Jeff Yass first reported a position in PEPLU in Q3 2022 and held it in 1 quarter. The position peaked at $106K in Q3 2022. 6 funds tracked by Wall St. Rank hold PEPLU as of Q4 2022.

  • Jeff Yass reported no remaining PepperLime Health Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
  • Jeff Yass sold 10,656 PepperLime Health Acquisition Corporation Unit shares in Q4 2022, an estimated $106K.
  • Jeff Yass first reported a position in PepperLime Health Acquisition Corporation Unit in Q3 2022 and held it in 1 quarter.
  • Jeff Yass's PepperLime Health Acquisition Corporation Unit position peaked at $106K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Unit as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.